News

Every once in a while, a breakthrough doesn't just advance medicine—it changes the conversation entirely.

BMJ Group Press Release  A brisk walking pace, and the amount of time spent at this speed, may lower the risk of heart rhythm abnormalities, such as atrial fibrillation, tachycardia (rapid heartbeat), and bradycardia (very slow...

Eko Health Press Release  SAN FRANCISCO, April 15, 2025 -- Eko Health, a global leader in AI-enabled cardiopulmonary care, today announced its launch in the United Kingdom—one of the world's largest healthcare markets....

CardioFocus Press Release  MARLBOROUGH, Mass. -- CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac arrhythmias, announced the continuation of the Quick AF study, which evaluates the...

LUMA Vision Press Release  DUBLIN, April 16, 2025 -- LUMA Vision Ltd., an innovative leader in advanced cardiac imaging and navigation, today announced the FDA clearance of its VERAFEYE™ Visualization Platform. This novel...

The American College of Cardiology Press Release  WASHINGTON (Apr 14, 2025) - Complications during pregnancy (or adverse pregnancy outcomes), like gestational diabetes and newly developed high blood pressure, act as nature’s...

BioCardia Press Release  SUNNYVALE, Calif., April 15, 2025 -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced that...

Health care professionals are encouraged to discuss sleep health with patients, and targeted research is needed to identify effective interventions to improve sleep health and reduce the risk of cardiometabolic health conditions.

Catheter Precision Press Release  Fort Mill, S.C., April 14, 2025 --  Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac...

Bristol Myers Squibb Press Release  PRINCETON, N.J. -- Bristol Myers Squibb (NYSE: BMY) today announced the Phase 3 ODYSSEY-HCM trial evaluating Camzyos (mavacamten) for the treatment of adult patients with...